Patents by Inventor Janko Nikolich-Zugich

Janko Nikolich-Zugich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEROLOGICAL ASSAYS FOR SARS-COV-2
    Publication number: 20230221320
    Abstract: Provided herein is a test system comprising severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. Also provided are methods of detecting SARS-CoV-2 antibodies in a sample using the test system.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Deepta Bhattacharya, Ryan Sprissler, Janko Nikolich-Zugich, Matthew Kaplan, Tyler Ripperger, Jennifer Uhrlaub, Makiko Watanabe, Rachel Wong
  • Serological assays for SARS-CoV-2
    Patent number: 11119103
    Abstract: Provided herein is a test system comprising severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. Also provided are methods of detecting SARS-CoV-2 antibodies in a sample using the test system.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: September 14, 2021
    Assignee: Arizona Board of Regents on Behalf of the University of Arizona, a body corporate
    Inventors: Deepta Bhattacharya, Ryan Sprissler, Janko Nikolich-Zugich, Matthew Kaplan, Tyler Ripperger, Jennifer Uhrlaub, Makiko Watanabe, Rachel Wong
  • Methods and compositions for treating an alphavirus infection
    Patent number: 10882903
    Abstract: Methods and pharmaceutical compositions for preventing, treating or suppressing symptoms of a disorder associated with an alphavirus infection. In particular, the present invention relates to preventing, treating or suppressing symptoms of a disorder associated with an alphavirus infection through inhibiting the activity and/or expression of Transforming Growth Factor Beta (TGF-?) in a subject suffering from or at risk for suffering from an alphavirus infection.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: January 5, 2021
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Janko Nikolich-Zugich, Jennifer Uhrlaub
  • METHODS AND COMPOSITIONS FOR TREATING AN ALPHAVIRUS INFECTION
    Publication number: 20180134778
    Abstract: Methods and pharmaceutical compositions for preventing, treating or suppressing symptoms of a disorder associated with an alphavirus infection. In particular, the present invention relates to preventing, treating or suppressing symptoms of a disorder associated with an alphavirus infection through inhibiting the activity and/or expression of Transforming Growth Factor Beta (TGF-?) in a subject suffering from or at risk for suffering from an alphavirus infection.
    Type: Application
    Filed: May 18, 2016
    Publication date: May 17, 2018
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Janko Nikolich-Zugich, Jennifer Uhrlaub